Clinical Trials List
2022-05-01 - 2028-06-30
Phase I/II
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chong-Jen Yu 無
- 廖唯昱 無
- 吳尚俊 無
- 徐偉勛 無
- CHAO-CHI HO CHAO-CHI HO 無
- 楊景堯 無
- Chia-Chi Lin 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- Jih-Hsiang Lee 無
- 廖斌志 無
- 陳冠宇 無
- 蔡子修 無
- YEN-TING LIN 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- 李柏昕 Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Pai-Chien Chou Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Kai-Ling Lee Division of General Internal Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 蔡政軒 Division of General Internal Medicine
- Wu-Chou Su Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
- Chun-Hui Lee Division of Hematology & Oncology
- Chian-Wei Chen Division of General Internal Medicine
- Seu-Chun Yang Division of General Internal Medicine
- Chin-Wei Kuo Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
222 participants